News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smither John W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Smither John W (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.34, valued at
$6.8k
|
|
| 01/24/2023 |
4
| Smither John W (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 36,875 options to buy
@ $0.4688, valued at
$17.3k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Smither John W (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.13, valued at
$62.6k
|
|
| 01/31/2022 |
4
| Smither John W (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 60,000 options to buy
@ $8.01, valued at
$480.6k
|
|
| 01/31/2022 |
3
| Smither John W (Director) has filed a Form 3 on Applied Molecular Transport Inc. |
| 10/08/2021 |
4
| Smither John W (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $11.36, valued at
$454.4k
|
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/11/2021 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 500 shares
@ $32.9, valued at
$16.5k
Sold 1,250 shares
@ $32.9, valued at
$41.1k
Exercised 500 options to buy
@ $1.6806, valued at
$840.3 |
|
| 03/05/2021 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 9,500 shares
@ $0
Granted 28,800 options to buy
@ $32.44, valued at
$934.3k
Exercised 12,396 options to buy
@ $1.6806, valued at
$20.8k
|
|
| 03/03/2021 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 773 shares
@ $34.204, valued at
$26.4k
|
|
| 02/12/2021 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 750 shares
@ $35.64, valued at
$26.7k
Sold 2,000 shares
@ $35.64, valued at
$71.3k
Exercised 750 options to buy
@ $1.6806, valued at
$1.3k
|
|
| 02/03/2021 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,250 shares
@ $35, valued at
$43.8k
Sold 3,750 shares
@ $35, valued at
$131.3k
Exercised 1,250 options to buy
@ $1.6806, valued at
$2.1k
|
|
| 01/21/2021 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 500 shares
@ $30, valued at
$15k
Sold 1,250 shares
@ $30, valued at
$37.5k
Exercised 500 options to buy
@ $1.6806, valued at
$840.3 |
|
| 12/16/2020 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $30, valued at
$45k
Sold 3,750 shares
@ $30, valued at
$112.5k
Exercised 1,500 options to buy
@ $1.6806, valued at
$2.5k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Exercised 14,875 options to buy
@ $1.6806, valued at
$25k
|
|
| 03/03/2020 |
4
| Smither John W (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 12,000 options to buy
@ $27.61, valued at
$331.3k
|
|
| 01/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2018 |
4
| Smither John W (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $16.9, valued at
$338k
|
|
| 06/07/2018 |
4
| Smither John W (Director) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 15,000 options to buy
@ $12.07, valued at
$181.1k
|
|
| 04/18/2018 |
4
| Smither John W (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 170,000 options to buy
@ $19.59, valued at
$3.3M
|
|
| 04/18/2018 |
3
| Smither John W (CFO) has filed a Form 3 on Sienna Biopharmaceuticals, Inc. |
| 06/16/2017 |
4
| Smither John W (Director) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 10,000 options to buy
@ $22.11, valued at
$221.1k
|
|
| 06/17/2016 |
4
| Smither John W (Director) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 10,000 options to buy
@ $4.84, valued at
$48.4k
|
|
| 10/02/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 17,960 shares
@ $0
Disposed/sold 6,216 shares
@ $0
Disposed/sold 14,897 options to buy
@ $5.9, valued at
$87.9k
Disposed/sold 852 options to buy
@ $8.22, valued at
$7k
Disposed/sold 6,700 options to buy
@ $27.5, valued at
$184.3k
Disposed/sold 19,266 options to buy
@ $44.02, valued at
$848.1k
Disposed/sold 45,344 options to buy
@ $38.53, valued at
$1.7M
|
|
| 09/28/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Exercised 14,017 options
@ $4.84, valued at
$67.8k
|
|
| 09/24/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Sold 13,272 shares
@ $74.9, valued at
$994.1k
Sold 13,646 shares
@ $74.9, valued at
$1M
Sold 13,154 shares
@ $74.9, valued at
$985.2k
Sold 13,763 shares
@ $74.9, valued at
$1M
Exercised 13,272 options
@ $8.22, valued at
$109.1k
Exercised 13,400 options
@ $27.5, valued at
$368.5k
Exercised 246 options
@ $27.5, valued at
$6.8k
Exercised 13,154 options
@ $27.5, valued at
$361.7k
Exercised 13,763 options
@ $44.02, valued at
$605.8k
|
|
| 09/23/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,054 shares
@ $74.95, valued at
$79k
Sold 3,476 shares
@ $74.9, valued at
$260.4k
Sold 2,115 shares
@ $74.9, valued at
$158.4k
Gifted 1,400 shares
@ $0
Exercised 1,054 options
@ $8.22, valued at
$8.7k
Exercised 3,476 options
@ $8.22, valued at
$28.6k
Exercised 2,115 options
@ $8.22, valued at
$17.4k
|
|
| 09/23/2015 |
4/A
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Granted 5,409 shares
@ $0
Sold 2,041 shares
@ $45.49, valued at
$92.8k
|
|
|
|
|